Forest/Paion’s Desmoteplase Program In Question After Failed Stroke Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Companies announce a Phase III study in acute ischemic stroke patients failed to show an efficacy benefit over placebo.